4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-010835
Executive VP Global Operations sold 3,192 shares at $17.67 ($56,399)
- Executive VP Global Operations acquired 9,280 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
de Notaristefani Carlo · Executive VP Global Operations
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-14 | Exercise or conversion : show line 1 in the form | +9,280 | 21,400.73 | D | ||
| 2019-02-14 | Sale : show line 2 in the form | −3,192 | $17.67 | $56,399 | 18,208.73 | D |
| Open-market sales · 3,192 sh · avg $17.67 · $56,399 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-14 | Exercise or conversion : show line 3 in the form Restricted Share Units | −9,280 | 18,560 | D |
Loading xslF345X03/doc4.xml…